Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

24.51
Delayed Data
As of Sep 23
 -0.79 / -3.12%
Today’s Change
12.25
Today|||52-Week Range
25.50
+35.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues104.9M111.2M104.8M116.7M
 
 
 
 
 
Cost of Goods Sold20.3M20.3M19.9M20.3M
 
 
 
 
 
Depreciation And Amortization27.6M27.8M27.7M27.7M
 
 
 
 
 
 
Operating ExpensesGross Income56.9M63.1M57.2M68.7M
 
 
 
 
 
General Expenses44.7M64.7M58.7M59.1M
 
 
 
 
 
Research And Development4.6M6.3M5.9M7.1M
 
 
 
 
 
Total Operating Expenses92.7M112.7M106.3M107.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income12.2M-1.6M-1.5M9.6M
 
 
 
 
 
Extraordinary Credit830.0K29.9M177.0K110.0K
 
 
 
 
 
Extraordinary Charge-10.4M-54.9M-3.6M-6.4M
 
 
 
 
 
Interest Expense On Debt22.0M22.7M22.1M19.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.3M-48.9M-26.9M-16.2M
 
 
 
 
 
Income Taxes-7.6M-18.2M-6.0M-5.7M
 
 
 
 
 
Net Income-11.8M-30.7M-20.9M-10.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.3M60.6M60.9M61.2M
 
 
 
 
 
Shares To Calculate EPS Diluted60.3M60.6M60.9M61.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.51-$0.34-$0.17
 
 
 
 
 
EPS Diluted-$0.20-$0.51-$0.34-$0.17